The 3-ketosteroid-Δ-dehydrogenase5 (KsdD) from Arthrobacter simplex converts cortisone acetate to prednisone acetate, an important step in steroid catabolism. To achieve sustainable and efficient enzyme production, we employed computer-aided screening, structural analysis, and combinatorial experiments to identify engineered KsdD variants (M1 and M3) with dual advantages of stability and active sites. M1 had a 8.2-fold longer half-life (19.6 h at 30 °C) than KsdD-WT, an 11.8 °C higher half-inactivation temperature (T), and a 10.6 °C higher melting temperature (T). M3 had 3.82-fold higher catalytic activity than WT, a 3.9-fold longer half-life at 30 °C, and higher T and T by 14 °C and 6.9 °C, respectively. Furthermore, kinetic and microscale thermophoresis analyses revealed M3 exhibited higher catalytic efficiency due to its larger enzymatic channel. Molecular dynamics simulations showed M1 promoted tighter secondary structure packing, reduced residue flexibility, and increased hydrogen bond formation, ensuring enzyme stability and activity at elevated temperatures. Under industrial conditions, M1 converted >96 % cortisone acetate within 12 h at 30 °C with a 60 g·L substrate dosage and 6 g·L cell mass, whereas the M3 conversion rate was 95 %. This study demonstrates a robust strategy for developing efficient enzyme mutants, facilitating sustainable industrial production of prednisone acetate with a minimal enzyme dosage.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2024.137855DOI Listing

Publication Analysis

Top Keywords

prednisone acetate
12
catalytic efficiency
8
arthrobacter simplex
8
enzyme dosage
8
cortisone acetate
8
efficient enzyme
8
longer half-life
8
higher catalytic
8
enzyme
5
acetate
5

Similar Publications

Background: Androgen receptor pathway inhibitors (apalutamide [APA], enzalutamide [ENZ], abiraterone acetate plus prednisone [AAP]) combined with androgen-deprivation therapy (ADT) are effective life-prolonging treatment options for metastatic hormone-sensitive prostate cancer (mHSPC). We evaluated the impact of upfront therapy for mHSPC on outcomes in real-world clinical practice in the United States.

Methods: This retrospective, observational cohort study used electronic healthcare records from the ConcertAI RWD 360 Prostate Cancer Dataset.

View Article and Find Full Text PDF

Despite several studies documenting secondary metabolite (SM) production by endophytes, their commercial use is often limited owing to the research lacunae in the underlying biosynthetic pathway and the corresponding metabolic flux. Combining epigenetic modulation with RNA-Seq analysis constitutes a promising approach for inducing regulatory gene(s) and thereby identifying their role in SM biosynthesis. Our earlier studies had identified the hypomethylating effects of prednisone in umbelliferone (UMB) (7-hydroxyl coumarin) producing endophytic Fusarium oxysporum isolate, ZzEF8 isolated from Zingiber zerumbet rhizomes.

View Article and Find Full Text PDF

The 3-ketosteroid-Δ-dehydrogenase5 (KsdD) from Arthrobacter simplex converts cortisone acetate to prednisone acetate, an important step in steroid catabolism. To achieve sustainable and efficient enzyme production, we employed computer-aided screening, structural analysis, and combinatorial experiments to identify engineered KsdD variants (M1 and M3) with dual advantages of stability and active sites. M1 had a 8.

View Article and Find Full Text PDF

Objective: To assess the therapeutic efficacy of abiraterone combined with prednisone in patients with castration-resistant prostate cancer (CRPC) and investigate its effects on miR-221/222 expression.

Methods: A retrospective cohort of 43 CRPC patients from Henan Provincial People's Hospital, People's Hospital of Zhengzhou University was divided into two groups: the treated group (n=22, treated with abiraterone and prednisone) and the control group (n=21, treated with prednisone acetate alone). Expression of miR-221/222 was quantified in CRPC cell lines using quantitative fluorescence polymerase chain reaction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!